(2E)-3-(3-fluorophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

4-Bromobenzoylacetonitrile, 96.0%, 1g

Objectif Plan PLPHi 20x/0,40 à contraste de phase IOS corrigé à l'infini

2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylsulfonyl)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol, 97%, 10mg

2,7-Diazaspiro[3.5]nonane-7-carboxylic acid 1,1-dimethyl ethyl ester, 95.0%, 25g

4-Methyl-4-phenylimidazolidin-2-one, 98%, 500mg

2-Amino-benzothiazole-6-carboxylic acid methyl ester, 95.0%, 25g

2,7,8-trimethyl-4-quinolinecarboxylic acid, 95.0%, 1g

Germanium(IV) Oxide25g

6,7,8,9-Tetrahydro-5H-pyrrolo[2,3-b:5,4-c']dipyridine, 95.0%, 1g

(2S,4S)-1-(tert-Butoxycarbonyl)-4-(trifluoromethyl)pyrrolidine-2-carboxylic acid, 95.0%, 100mg

METHYL 5-NITRO-1H-INDAZOLE-3-CARBOXYLATE, 95%, 500mg

Plaques CCM ADAMANT UV254, 20 x 20 cm, 25 pièce(s)